Afinitor – Anti-Cancer Therapy
Key Data:
Drug (Brand/Generic)
Afinitor (formerly RAD001)/ everolimus
Company/Licensee
Novartis
Therapy Class
Anti-neoplastic agent
Product Description
mTOR inhibitor
Current Indication
Renal cell carcinoma
Market Sector
Oncology
Development Status
Approved in the US and Europe; under review in Japan and Switzerland
